ID   Me4023
AC   CVCL_V021
SY   4023
DR   Wikidata; Q54904966
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9743519;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RA   Grazia G.;
RT   "Co-targeting of oncogenic and death receptors pathways in human
RT   melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic
RT   strategy.";
RL   Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy.
//
RX   PubMed=9743519; DOI=10.1084/jem.188.6.1005; PMCID=PMC2212536;
RA   Lupetti R., Pisarra P., Verrecchia A., Farina C., Nicolini G.,
RA   Anichini A., Bordignon C., Sensi M., Parmiani G., Traversari C.;
RT   "Translation of a retained intron in tyrosinase-related protein (TRP)
RT   2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared
RT   human melanoma antigen not expressed in normal cells of the
RT   melanocytic lineage.";
RL   J. Exp. Med. 188:1005-1016(1998).
//
RX   PubMed=25576923; DOI=10.18632/oncotarget.2995; PMCID=PMC4413617;
RA   Loria R., Bon G., Perotti V., Gallo E., Bersani I., Baldassari P.,
RA   Porru M., Leonetti C., Di Carlo S., Visca P., Brizzi M.F.,
RA   Anichini A., Mortarini R., Falcioni R.;
RT   "Sema6A and Mical1 control cell growth and survival of BRAFV600E human
RT   melanoma cells.";
RL   Oncotarget 6:2779-2793(2015).
//